Harbor Capital Advisors’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6M | Sell |
78,560
-7,400
| -9% | -$1.28M | 0.57% | 31 |
|
|
2025
Q1 | $13.4M | Buy |
85,960
+1,087
| +1% | +$169K | 0.61% | 25 |
|
|
2024
Q4 | $11.7M | Sell |
84,873
-2,429
| -3% | -$334K | 0.51% | 49 |
|
|
2024
Q3 | $13M | Buy |
87,302
+35,102
| +67% | +$5.24M | 0.57% | 32 |
|
|
2024
Q2 | $7.12M | Buy |
52,200
+30,194
| +137% | +$4.12M | 0.54% | 24 |
|
|
2024
Q1 | $3.33M | Buy |
22,006
+9,921
| +82% | +$1.5M | 0.43% | 29 |
|
|
2023
Q4 | $1.52M | Sell |
12,085
-2,050
| -15% | -$258K | 0.29% | 92 |
|
|
2023
Q3 | $1.32M | Buy |
14,135
+2,092
| +17% | +$196K | 0.28% | 88 |
|
|
2023
Q2 | $1.07M | Sell |
12,043
-158
| -1% | -$14.1K | 0.22% | 118 |
|
|
2023
Q1 | $1.31M | Sell |
12,201
-1,009
| -8% | -$108K | 0.38% | 76 |
|
|
2022
Q4 | $1.61M | Sell |
13,210
-285
| -2% | -$34.8K | 1.56% | 21 |
|
|
2022
Q3 | $1.39M | Sell |
13,495
-1,492
| -10% | -$154K | 1.28% | 25 |
|
|
2022
Q2 | $1.39M | Sell |
14,987
-40
| -0.3% | -$3.72K | 1.06% | 28 |
|
|
2022
Q1 | $1.76M | Sell |
15,027
-2,189
| -13% | -$257K | 0.83% | 37 |
|
|
2021
Q4 | $2.32M | Buy |
+17,216
| New | +$2.32M | 0.84% | 40 |
|